ResMed Inc. (0KW4.L)
USD 215.0
(1.0%)
USD 215.0
(1.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 1.02 Billion USD | 13.75% |
| 2023 | 897.55 Million USD | 15.15% |
| 2022 | 779.43 Million USD | 64.26% |
| 2021 | 474.5 Million USD | -23.67% |
| 2020 | 621.67 Million USD | 53.65% |
| 2019 | 404.59 Million USD | 28.2% |
| 2018 | 315.58 Million USD | -7.8% |
| 2017 | 342.28 Million USD | -2.87% |
| 2016 | 352.4 Million USD | -0.14% |
| 2015 | 352.88 Million USD | 2.2% |
| 2014 | 345.27 Million USD | 12.42% |
| 2013 | 307.13 Million USD | 20.52% |
| 2012 | 254.85 Million USD | 12.28% |
| 2011 | 226.98 Million USD | 19.41% |
| 2010 | 190.08 Million USD | 29.8% |
| 2009 | 146.44 Million USD | 32.77% |
| 2008 | 110.3 Million USD | 66.36% |
| 2007 | 66.3 Million USD | -24.84% |
| 2006 | 88.21 Million USD | 36.16% |
| 2005 | 64.78 Million USD | 13.09% |
| 2004 | 57.28 Million USD | 25.27% |
| 2003 | 45.72 Million USD | 21.92% |
| 2002 | 37.5 Million USD | 222.49% |
| 2001 | 11.63 Million USD | -47.67% |
| 2000 | 22.22 Million USD | 38.05% |
| 1999 | 16.1 Million USD | 51.89% |
| 1998 | 10.6 Million USD | 41.33% |
| 1997 | 7.5 Million USD | 66.67% |
| 1996 | 4.5 Million USD | 60.71% |
| 1995 | 2.8 Million USD | 133.33% |
| 1994 | 1.2 Million USD | 50.0% |
| 1993 | 800 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 1.02 Billion USD | 13.75% |
| 2024 Q2 | 208.8 Million USD | -4.84% |
| 2024 Q1 | 219.42 Million USD | -4.46% |
| 2024 Q4 | 292.23 Million USD | -2.75% |
| 2024 Q3 | 300.49 Million USD | 43.91% |
| 2023 Q2 | 224.91 Million USD | 6.86% |
| 2023 FY | 897.55 Million USD | 15.15% |
| 2023 Q4 | 229.66 Million USD | -1.22% |
| 2023 Q1 | 210.47 Million USD | 7.9% |
| 2023 Q3 | 232.5 Million USD | 3.37% |
| 2022 Q1 | 203.61 Million USD | 4.36% |
| 2022 FY | 779.43 Million USD | 64.26% |
| 2022 Q4 | 195.06 Million USD | 8.97% |
| 2022 Q3 | 179.01 Million USD | -11.27% |
| 2022 Q2 | 201.75 Million USD | -0.91% |
| 2021 Q1 | 178.37 Million USD | 0.3% |
| 2021 Q3 | -78.48 Million USD | -143.72% |
| 2021 FY | 474.5 Million USD | -23.67% |
| 2021 Q2 | 179.51 Million USD | 0.64% |
| 2021 Q4 | 195.09 Million USD | 348.59% |
| 2020 Q2 | 160.55 Million USD | 33.63% |
| 2020 Q4 | 177.83 Million USD | 9.01% |
| 2020 FY | 621.67 Million USD | 53.65% |
| 2020 Q3 | 163.13 Million USD | 1.61% |
| 2020 Q1 | 120.14 Million USD | 74.64% |
| 2019 Q2 | 124.63 Million USD | 17.88% |
| 2019 Q4 | 68.79 Million USD | -34.74% |
| 2019 Q1 | 105.73 Million USD | -3.71% |
| 2019 Q3 | 105.41 Million USD | -15.42% |
| 2019 FY | 404.59 Million USD | 28.2% |
| 2018 Q2 | 9.52 Million USD | -88.94% |
| 2018 FY | 315.58 Million USD | -7.8% |
| 2018 Q4 | 109.81 Million USD | -0.28% |
| 2018 Q1 | 86.12 Million USD | -15.24% |
| 2018 Q3 | 110.12 Million USD | 1055.93% |
| 2017 Q3 | 87.82 Million USD | 14.44% |
| 2017 Q2 | 76.74 Million USD | 0.84% |
| 2017 Q4 | 101.61 Million USD | 15.7% |
| 2017 FY | 342.28 Million USD | -2.87% |
| 2017 Q1 | 76.1 Million USD | -8.44% |
| 2016 Q3 | 88.45 Million USD | -2.27% |
| 2016 Q2 | 90.51 Million USD | 12.58% |
| 2016 Q1 | 80.4 Million USD | -8.07% |
| 2016 FY | 352.4 Million USD | -0.14% |
| 2016 Q4 | 83.12 Million USD | -6.03% |
| 2015 FY | 352.88 Million USD | 2.2% |
| 2015 Q4 | 87.46 Million USD | -3.87% |
| 2015 Q3 | 90.98 Million USD | -0.22% |
| 2015 Q1 | 83.26 Million USD | -5.1% |
| 2015 Q2 | 91.18 Million USD | 9.51% |
| 2014 Q4 | 87.73 Million USD | -2.48% |
| 2014 Q2 | 86.63 Million USD | 7.05% |
| 2014 Q1 | 80.93 Million USD | 10.84% |
| 2014 FY | 345.27 Million USD | 12.42% |
| 2014 Q3 | 89.96 Million USD | 3.85% |
| 2013 Q1 | 71.26 Million USD | -7.26% |
| 2013 Q4 | 73.01 Million USD | -14.01% |
| 2013 FY | 307.13 Million USD | 20.52% |
| 2013 Q3 | 84.91 Million USD | 8.94% |
| 2013 Q2 | 77.94 Million USD | 9.37% |
| 2012 Q3 | 64.61 Million USD | 2.77% |
| 2012 Q4 | 76.84 Million USD | 18.93% |
| 2012 Q1 | 50.51 Million USD | -13.6% |
| 2012 Q2 | 62.87 Million USD | 24.45% |
| 2012 FY | 254.85 Million USD | 12.28% |
| 2011 Q2 | 58.45 Million USD | 3.08% |
| 2011 Q1 | 56.7 Million USD | 6.66% |
| 2011 FY | 226.98 Million USD | 19.41% |
| 2011 Q4 | 58.47 Million USD | -65.3% |
| 2011 Q3 | 168.51 Million USD | 188.27% |
| 2010 Q3 | 48.83 Million USD | 6.2% |
| 2010 Q2 | 45.98 Million USD | 9.22% |
| 2010 Q1 | 42.1 Million USD | -7.2% |
| 2010 FY | 190.08 Million USD | 29.8% |
| 2010 Q4 | 53.16 Million USD | 8.87% |
| 2009 Q3 | 39.19 Million USD | 15.79% |
| 2009 Q2 | 33.85 Million USD | 20.79% |
| 2009 Q1 | 28.02 Million USD | -5.43% |
| 2009 FY | 146.44 Million USD | 32.77% |
| 2009 Q4 | 45.37 Million USD | 15.75% |
| 2008 Q1 | 24.12 Million USD | -12.82% |
| 2008 FY | 110.3 Million USD | 66.36% |
| 2008 Q4 | 29.63 Million USD | -0.17% |
| 2008 Q3 | 29.68 Million USD | 10.51% |
| 2008 Q2 | 26.86 Million USD | 11.34% |
| 2007 Q1 | 24.99 Million USD | 8.25% |
| 2007 FY | 66.3 Million USD | -24.84% |
| 2007 Q3 | -15.36 Million USD | -152.99% |
| 2007 Q2 | 28.99 Million USD | 15.98% |
| 2007 Q4 | 27.67 Million USD | 280.1% |
| 2006 Q2 | 22.31 Million USD | 35.71% |
| 2006 FY | 88.21 Million USD | 36.16% |
| 2006 Q1 | 16.44 Million USD | 5.55% |
| 2006 Q4 | 23.09 Million USD | -12.4% |
| 2006 Q3 | 26.36 Million USD | 18.14% |
| 2005 Q2 | 17.4 Million USD | 24.97% |
| 2005 Q4 | 15.57 Million USD | -12.86% |
| 2005 FY | 64.78 Million USD | 13.09% |
| 2005 Q3 | 17.87 Million USD | 2.72% |
| 2005 Q1 | 13.92 Million USD | -12.17% |
| 2004 Q4 | 15.85 Million USD | 5.5% |
| 2004 Q1 | 12.24 Million USD | -9.43% |
| 2004 Q3 | 15.02 Million USD | 6.2% |
| 2004 FY | 57.28 Million USD | 25.27% |
| 2004 Q2 | 14.15 Million USD | 15.53% |
| 2003 Q1 | 9.57 Million USD | -2.44% |
| 2003 Q3 | 12.25 Million USD | 17.97% |
| 2003 Q2 | 10.38 Million USD | 8.49% |
| 2003 FY | 45.72 Million USD | 21.92% |
| 2003 Q4 | 13.52 Million USD | 10.4% |
| 2002 Q2 | 8.77 Million USD | 2.82% |
| 2002 Q4 | 9.81 Million USD | -5.48% |
| 2002 FY | 37.5 Million USD | 222.49% |
| 2002 Q3 | 10.37 Million USD | 18.23% |
| 2002 Q1 | 8.53 Million USD | 2.3% |
| 2001 Q2 | 6.89 Million USD | 4.83% |
| 2001 Q4 | 8.34 Million USD | 181.87% |
| 2001 FY | 11.63 Million USD | -47.67% |
| 2001 Q1 | 6.58 Million USD | 6.28% |
| 2001 Q3 | -10.19 Million USD | -247.78% |
| 2000 Q1 | 4.8 Million USD | 4.35% |
| 2000 Q2 | 5.4 Million USD | 12.5% |
| 2000 Q4 | 6.19 Million USD | 6.05% |
| 2000 Q3 | 5.83 Million USD | 8.11% |
| 2000 FY | 22.22 Million USD | 38.05% |
| 1999 Q4 | 4.6 Million USD | 4.55% |
| 1999 FY | 16.1 Million USD | 51.89% |
| 1999 Q1 | 3.2 Million USD | 6.67% |
| 1999 Q2 | 3.9 Million USD | 21.88% |
| 1999 Q3 | 4.4 Million USD | 12.82% |
| 1998 Q1 | 2.2 Million USD | 4.76% |
| 1998 Q4 | 3 Million USD | -3.23% |
| 1998 Q3 | 3.1 Million USD | 34.78% |
| 1998 Q2 | 2.3 Million USD | 4.55% |
| 1998 FY | 10.6 Million USD | 41.33% |
| 1997 Q2 | 1.7 Million USD | -5.56% |
| 1997 Q1 | 1.8 Million USD | 20.0% |
| 1997 Q3 | 1.9 Million USD | 11.76% |
| 1997 Q4 | 2.1 Million USD | 10.53% |
| 1997 FY | 7.5 Million USD | 66.67% |
| 1996 FY | 4.5 Million USD | 60.71% |
| 1996 Q4 | 1.5 Million USD | 25.0% |
| 1996 Q3 | 1.2 Million USD | 33.33% |
| 1996 Q1 | 900 Thousand USD | 28.57% |
| 1996 Q2 | 900 Thousand USD | 0.0% |
| 1995 Q1 | 700 Thousand USD | 133.33% |
| 1995 Q3 | 700 Thousand USD | 0.0% |
| 1995 Q4 | 700 Thousand USD | 0.0% |
| 1995 FY | 2.8 Million USD | 133.33% |
| 1995 Q2 | 700 Thousand USD | 0.0% |
| 1994 FY | 1.2 Million USD | 50.0% |
| 1994 Q4 | 300 Thousand USD | 0.0% |
| 1994 Q2 | 300 Thousand USD | 0.0% |
| 1994 Q1 | 300 Thousand USD | 50.0% |
| 1994 Q3 | 300 Thousand USD | 0.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 Q4 | 200 Thousand USD | 0.0% |
| 1993 Q3 | 200 Thousand USD | 0.0% |
| 1993 Q2 | 200 Thousand USD | 0.0% |
| 1993 FY | 800 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 845.846% |
| Accuray Incorporated | -15.54 Million USD | 6667.713% |
| Align Technology, Inc. | 445.05 Million USD | -129.4% |
| Elevance Health Inc. | 5.98 Billion USD | 82.947% |
| AxoGen, Inc. | -21.71 Million USD | 4801.377% |
| Boston Scientific Corporation | 1.59 Billion USD | 35.91% |
| CVS Health Corporation | 8.34 Billion USD | 87.764% |
| Cardinal Health, Inc. | 852 Million USD | -19.83% |
| Centene Corporation | 2.7 Billion USD | 62.215% |
| DaVita Inc. | 691.53 Million USD | -47.635% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 80.524% |
| Hologic, Inc. | 789.5 Million USD | -29.316% |
| Humana Inc. | 2.48 Billion USD | 58.981% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -20.817% |
| Laboratory Corporation of America Holdings | 418 Million USD | -144.247% |
| Masimo Corporation | 81.5 Million USD | -1152.701% |
| McKesson Corporation | 3 Billion USD | 65.991% |
| Patterson Companies, Inc. | 185.93 Million USD | -449.102% |
| Quest Diagnostics Incorporated | 854 Million USD | -19.549% |
| Henry Schein, Inc. | 416 Million USD | -145.421% |
| Teladoc Health, Inc. | -220.36 Million USD | 563.294% |
| Universal Health Services, Inc. | 717.79 Million USD | -42.234% |
| Veeva Systems Inc. | 525.7 Million USD | -94.206% |
| Baxter International Inc. | 2.65 Billion USD | 61.561% |
| Becton, Dickinson and Company | 1.48 Billion USD | 31.203% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 43.217% |
| Danaher Corporation | 4.2 Billion USD | 75.692% |
| Stryker Corporation | 3.16 Billion USD | 67.742% |
| Medtronic plc | 3.67 Billion USD | 72.227% |